Ddavp and Cytarabine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ddavp (desmopressin acetate) and Cytarabine (cytarabine). Common drug interactions include hypocalcaemia among females and abdominal distension among males.
The phase IV clinical study analyzes what interactions people have when they take Ddavp and Cytarabine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Ddavp?
Ddavp has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 2,614 Ddavp users. Check the latest studies of Ddavp.
What is Cytarabine?
Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.
11 people who take Ddavp and Cytarabine together, and have interactions are studied.

What are the common drug interactions of Ddavp and Cytarabine, by gender? *:
female:
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
- Mucosal inflammation (infection of mucous membrane)
- Stomatitis (inflammation of mucous membrane of mouth)
- Urinary tract infection enterococcal
- Asthenia (weakness)
- Fatigue (feeling of tiredness)
male:
- Abdominal distension
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Blood bilirubin increased
- Death
- Hypokalaemia (low potassium)
- Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
What are the common drug interactions of Ddavp and Cytarabine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Atelectasis (partial or complete collapse of the lung)
- Hypernatraemia (an abnormally high plasma concentration of sodium ions)
- Hypertension (high blood pressure)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
- Mucosal inflammation (infection of mucous membrane)
- Stomatitis (inflammation of mucous membrane of mouth)
20-29:
n/a
30-39:
n/a
40-49:
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
50-59:
- Weight decreased
- Asthenia (weakness)
- Fatigue (feeling of tiredness)
- Hypophagia (reduced food intake)
- Lethargy (tiredness)
- Nausea (feeling of having an urge to vomit)
- Vomiting
60+:
- Abdominal distension
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Blood bilirubin increased
- Death
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 63.64%
- Hypernatraemia (an abnormally high plasma concentration of sodium ions): 2 people, 18.18%
- Weakness: 1 person, 9.09%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 1 person, 9.09%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
- Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 9.09%
- Diabetes Insipidus - Nephrogenic (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Ddavp and Cytarabine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ddavp (2,614 reports)
- Cytarabine (65,358 reports)
Browse all drug interactions of Ddavp and Cytarabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ddavp:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cytarabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ddavp and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cytarabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on desmopressin acetate and cytarabine (the active ingredients of Ddavp and Cytarabine, respectively), and Ddavp and Cytarabine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nitrofurazone cause Red Blood Cell Sedimentation Rate Increased? - 12 seconds ago
- Creatinine Renal Clearance Decreased and drugs of ingredients of lidocaine - 17 seconds ago
- Tylenol and Pancreatitis Acute for Women aged 30-39 - 46 seconds ago
- Pvt and drugs of ingredients of baclofen - 49 seconds ago
- Drug interactions of Venlafaxine Hydrochloride and Pramipexole Dihydrochloride - 51 seconds ago
- Could Fentora cause Pain Exacerbated? - 53 seconds ago
- Simvastatin and Atrial Tachycardia for Women aged 60+ - 58 seconds ago
- Zolpidem Tatrate vs. Geodon, side effect and effectiveness comparison - 59 seconds ago
- Infarction and drugs of ingredients of hydrocortisone - a minute ago
- Drug interactions of Fluoxetine and Haldol - a minute ago